Clinical Trial Update: Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking Agents [Phase 4]

View source ↗

Summary

A Phase 4 trial update investigating the physiopathologic effects of neuromuscular blocking agents in patients with traumatic brain injury and intracranial hype…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Hypertension
• Traumatic Brain Injury

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Traumatic Brain Injury, Intracranial Hypertension | Phase 4 | Status: UNKNOWN